海康威视（002415.SZ）8月5日在投资者互动平台表示，您好，海康机器人目前包括机器视觉、移动机 器人、关节机器人三块主要业务，机器视觉包括2D标准产品线、智能产品线和3D产品线；移动机器人 包括潜伏系列、叉取系列、移重载系列、复合系列、料箱系列和配套组件；关节机器人业务已发布多款 六轴垂直多关节机器人和水平多关节机器人。 （文章来源：每日经济新闻） 每经AI快讯，有投资者在投资者互动平台提问：尊敬的董秘您好，能否详细完整介绍一下贵司在机器 人领域的业务？ ...

证券代码：871478 证券简称：巨能股份 公告编号：2025-038 宁夏巨能机器人股份有限公司 投资者关系活动记录表 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 投资者关系活动类别 □特定对象调研 二、 投资者关系活动情况 活动时间：2025 年 5 月 27 日 15:00-16:00 活动地点：线上调研 □业绩说明会 □媒体采访 □现场参观 □新闻发布会 □分析师会议 □路演活动 √其他 （线上会议） 参会单位及人员：开源证券股份有限公司、中泰证券股份有限公司、浙商证 券股份有限公司、招银理财有限责任公司、长江证券股份有限公司、山西证券股 份有限公司、民生证券股份有限公司、联储证券股份有限公司、华鑫证券有限责 任公司、国泰海通证券、国都证券有限责任公司、财富证券有限责任公司（自营）、 易方达基金管理有限公司、西部利得基金管理有限公司、九泰基金基金管理有限 公司、汇丰晋信基金管理有限公司、国泰基金、长城财富资管、英大保险、中兴 威投资管理有限公司、泰石投资管理有限公司、尚诚资产管理有限责 ...

Summary of the Conference Call on Orthopedic Surgical Robots Industry Overview - The domestic orthopedic surgical robot market is in its early stages with nearly 20 participating brands, but the installation volume is limited, with approximately 30 spinal robots, a few dozen joint robots, and only one or two trauma robots installed annually, indicating a very low market penetration rate compared to laparoscopic robots [1][2][15]. Key Points and Arguments - **Complex Procurement Process**: The procurement decision-making process for orthopedic surgical robots is complex and time-consuming, typically taking about two years. It involves project initiation, budget approval, and tendering processes, with terminal prices usually in the range of several million RMB [1][3][4]. - **Patient Attitudes**: Patients generally have a positive attitude towards orthopedic robots, believing they provide more precise and safer surgical experiences. However, the immature fee structure and lack of comprehensive insurance coverage for these technologies create economic pressure on hospitals [5][6]. - **Cost Comparison**: The surgical costs for orthopedic robots are significantly higher than traditional surgeries, with self-pay amounts varying widely across regions. For instance, hospitals in Jiangsu and Zhejiang charge around 35,000 RMB, while others may charge between 20,000 RMB to several thousand RMB [8][9]. - **Price Trends**: The terminal price for spinal robots is approximately 11 million RMB, while joint robots can cost around 12 million RMB for a full set. There has been a noticeable decline in prices over the past few years, with spinal robot prices dropping from around 16-17 million RMB to about 11-12 million RMB [10][12]. - **Market Penetration**: The penetration rate of orthopedic surgical robots in China is extremely low, with only a few thousand surgeries performed using these robots compared to over 300,000 total orthopedic surgeries annually. In contrast, international penetration rates are reported to be between 10% to 20% [15]. - **Commercialization Challenges**: The slow commercialization speed of orthopedic surgical robots compared to laparoscopic robots is attributed to their narrow range of indications and lack of strong policy support, unlike laparoscopic robots which benefit from broader applications and guaranteed procurement tasks [15][16]. - **Future Revenue Models**: The business model for orthopedic robots could evolve to drive revenue growth through consumables, but currently, equipment sales dominate revenue streams, accounting for about 90% of income, with consumables contributing only 10% [16]. Additional Important Insights - **Technological Gaps**: Domestic spinal robot technology lags behind international leaders like Medtronic in areas such as preoperative planning and surgical navigation. However, domestic brands have advantages in cost control and maturity in orthopedic implant technology in the joint robot sector [17][18]. - **International Sales**: Companies like MicroPort have performed well in international markets due to their established global operations and product lines, allowing them to leverage existing sales channels for orthopedic robots [20][21]. - **Future Innovations**: While current spinal robot technology meets clinical needs with precision of 0.1 mm, future innovations may focus on operational processes rather than significant technological breakthroughs. In contrast, joint robot development may see more substantial advancements in soft tissue handling techniques [25][27]. This summary encapsulates the key insights from the conference call regarding the orthopedic surgical robot industry, highlighting the current market dynamics, challenges, and future opportunities.